Thursday, clinical research organization ICON Plc (ICLR) said that its Chairman John Climax will retire on December 31 and will be succeeded by Bruce Given who will assume office from January 1, 2010. Climax will continue as a member of the company's board.
Climax co-founded ICON with Ronan Lambe in 1990. In recognition of his contribution to the company over the past 20 years the board awarded him the title of Chairman Emeritus.
Dublin, Ireland-based Icon stated that Given has been serving the company as board member since 2004 and is currently holding the position of healthcare products consultant.
Earlier, Given served Encysive Pharmaceuticals as president and chief executive officer, prior to which had 9 years at Johnson & Johnson in several capacities including that of President, International, Ortho-Clinical Diagnostics and as Group Vice President and Head of U.S. Marketing & Sales, Research & Development for Janssen Pharmaceutica. Given was on the medical faculty at the University of Chicago before entering the pharmaceutical industry.
ICLR is currently trading at $21.81, up $0.06 or 0.25%, on a volume of 0.19 million shares on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.